Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
This information helps your doctor understand your health better
A new study published in The BMJ has found that adults with type 2 diabetes who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), may face a higher risk of developing non-scarring hair loss (alopecia) compared with patients taking other commonly prescribed diabetes medicines
Victozas patent in the US and Europe expired in late 2023, paving the way for companies like Teva to pursue generic versions
Berendsen AAM, Kang JH, van de Rest O, Feskens EJM, de Groot L, Grodstein F
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine
L- , - , L-
